Atlas Trials

A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users

Clinical trial NCT03200080 · TERMINATED

Trial details

NCT number
NCT03200080
Sponsor
Biotie Therapies Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Abuse Potential
Start date
2017-09-18
Primary completion
2017-11-28
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.